Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: Roles of IL-17 and TNF-α

被引:107
作者
Gradolatto, Angeline [1 ,2 ,3 ,4 ]
Nazzal, Dani [5 ]
Truffault, Frederique [1 ,2 ,3 ,4 ]
Bismuth, Jacky [1 ,2 ,3 ,4 ]
Fadel, Elie [6 ]
Foti, Maria [7 ]
Berrih-Aknin, Sonia [1 ,2 ,3 ,4 ]
机构
[1] INSERM, U974, Paris, France
[2] CNRS, UMR 7215, Paris, France
[3] Univ Paris 06, Paris, France
[4] AIM, Inst Myol, Paris, France
[5] Inst Pasteur, F-75015 Paris, France
[6] Hop Marie Lannelongue, Dept Thorac & Vasc Surg & Heart Lung Transplantat, F-92350 Le Plessis Robinson, France
[7] Univ Milano Bicocca, Genopolis Consortium, I-20126 Milan, Italy
关键词
Thymus; Chronic inflammation; Tconv cells; Treg cells; TNF-alpha; IL-17; REGULATORY T-CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NECROSIS-FACTOR-ALPHA; CONTROL AUTOIMMUNE INFLAMMATION; MEDIATED SUPPRESSION; ACETYLCHOLINE-RECEPTOR; RHEUMATOID-ARTHRITIS; INCREASED RESISTANCE; ETANERCEPT TREATMENT; REDUCED SENSITIVITY;
D O I
10.1016/j.jaut.2013.12.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myasthenia gravis (MG) is an autoimmune disease in which the thymus frequently presents follicular hyperplasia and signs of inflammation and T cells display a defect in suppressive regulation. Defects in a suppressive assay can indicate either the defective function of Treg cells or the resistance of Tconv cells to suppression by Treg cells. The aim of this study was to determine which cells were responsible for this defect and to address the mechanisms involved. We first performed cross-experiment studies using purified thymic Treg cells and Tconv cells from controls (CTRL) and MG patients. We confirmed that MG Treg cells were defective in suppressing CTRL Tconv proliferation, and we demonstrated for the first time that MG Tconv cells were resistant to Treg cell suppression. The activation of MG Tconv cells triggered a lower upregulation of FoxP3 and a higher upregulation of CD4 and CD25 than CTRL cells. To investigate the factors that could explain these differences, we analyzed the transcriptomes of purified thymic Treg and Tconv cells from MG patients in comparison to CTRL cells. Many of the pathways revealed by this analysis are involved in other autoimmune diseases, and T cells from MG patients exhibit a Th1/Th17/Tfh signature. An increase in IL-17-related genes was only observed in Treg cells, while increases in IFN-gamma, IL-21, and TNF-alpha were observed in both Treg and Tconv cells. These results were confirmed by PCR studies. In addition, the role of TNF-alpha in the defect in Tconv cells from MG patients was further confirmed by functional studies. Altogether, our results indicate that the immunoregulatory defects observed in MG patients are caused by both Treg cell and Tconv cell impairment and involve several pro-inflammatory cytokines, with TNF-alpha playing a key role in this process. The chronic inflammation present in the thymus of MG patients could provide an explanation for the escape of thymic T cells from regulation in the MG thymus. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:53 / 63
页数:11
相关论文
共 67 条
[1]  
AHARONOV A, 1975, LANCET, V2, P340
[2]  
Aissaoui A, 1999, ANN NEUROL, V46, P559, DOI 10.1002/1531-8249(199910)46:4<559::AID-ANA3>3.0.CO
[3]  
2-S
[4]   Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases [J].
Akdis, Muebeccel ;
Burgler, Simone ;
Crameri, Reto ;
Eiwegger, Thomas ;
Fujita, Hiroyuki ;
Gomez, Enrique ;
Klunker, Sven ;
Meyer, Norbert ;
O'Mahony, Liam ;
Palomares, Oscar ;
Rhyner, Claudio ;
Quaked, Nadia ;
Schaffartzik, Anna ;
Van De Veen, Willem ;
Zeller, Sabine ;
Zimmermann, Maya ;
Akdis, Cezmi A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (03) :701-U317
[5]   Human regulatory T cells and their role in autoimmune disease [J].
Baecher-Allan, Clare ;
Hafler, David A. .
IMMUNOLOGICAL REVIEWS, 2006, 212 :203-216
[6]   Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis [J].
Balandina, A ;
Lécart, S ;
Dartevelle, P ;
Saoudi, A ;
Berrih-Aknin, S .
BLOOD, 2005, 105 (02) :735-741
[7]  
Battaglia A, 2005, J BIOL REG HOMEOS AG, V19, P54
[8]   T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: Role of IL-2 [J].
Ben-Ami, Eyal ;
Miller, Ariel ;
Berrih-Aknin, Sonia .
AUTOIMMUNITY REVIEWS, 2014, 13 (02) :187-196
[9]   Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases [J].
Ben-Ami, Eyal ;
Berrih-Aknin, Sonia ;
Miller, Ariel .
AUTOIMMUNITY REVIEWS, 2011, 10 (07) :410-415
[10]   Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis [J].
Berrih-Aknin, Sonia ;
Ragheb, Samia ;
Le Panse, Rozen ;
Lisak, Robert P. .
AUTOIMMUNITY REVIEWS, 2013, 12 (09) :885-893